Alkermes plc. · Drugmakers

ALKS

Low riskNext report: Due any day

View price ↗

The short version

A profitable company with growing sales.

Going well

Sales up 27% in the latest quarter vs a year ago
Profitable, keeps 16% of sales as profit
Brings in more cash than it spends

Money moves

Insiders sold $83K in the last 30 days, all through pre-planned sales
Institutions added 1.4% to their holdings in the quarter ending June 2026 (229 bought, 187 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$44.45+1.9% that day

Company value: $7.5B; Share price times all shares
Price vs profit (P/E): 117.0x; You pay about $117 for each $1 of yearly profit
Price vs sales: 4.5x; Company value is 4.5 times a year of sales
Cash vs value: 7%; Cash as a share of company value

From ALKS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$496.0M+27% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $1.7B, up 11% from the 12 months before. Over 5 years, sales grew about 7.3% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of ALKS. Starting points are the company's recent numbers.

Sales growth+11% a yearRecently: +11% a yearProfit margin4%Last 12 months: 4.0%P/E at the end40xToday: 117.0x. Many steady companies trade at 12x to 25xShare count change+1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$2.8B

Profit in 5 years$112M

Price these guesses point to$25.50-43% vs $44.45 todayAbout -11% a year, before dividends

What today's price needs: with a 4% margin and a 40x P/E, sales would have to grow about 24% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/6Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.14.7%
PassDebt under half of equityNot relying on borrowed money.0.00x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.16.4%
MissProfitable every yearSteady profits, not one good year.3 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$480.3M
MissShare count not growingNot diluting owners. Falling means buybacks.+3.1% in 3 years

Revenue: $1.5B; -5.2% vs prior year
5-year growth: +7.3%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 3.55x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.